يعرض 1 - 10 نتائج من 12 نتيجة بحث عن '"Kentarou Kuroishi"', وقت الاستعلام: 1.40s تنقيح النتائج
  1. 1
    Safety and effectiveness of mirabegron in patients with overactive bladder aged ≥75 years: Analysis of a Japanese post-marketing study

    المؤلفون: Yumiko Nozawa, Daisuke Kato, Kentarou Kuroishi, Hiromi Tabuchi, Masaki Yoshida

    المصدر: LUTS: Lower Urinary Tract Symptoms. 11:30-38

    مصطلحات موضوعية: Male, medicine.medical_specialty, Urology, 030232 urology & nephrology, Adrenergic beta-3 Receptor Agonists, 03 medical and health sciences, 0302 clinical medicine, Quality of life, Product Surveillance, Postmarketing, Humans, Medicine, In patient, Mass index, Drug reaction, Aged, 030219 obstetrics & reproductive medicine, Urinary Bladder, Overactive, business.industry, Incidence (epidemiology), medicine.disease, Thiazoles, Treatment Outcome, Neurology, Overactive bladder, Concomitant, Quality of Life, Urological Agents, Acetanilides, Female, business, Mirabegron, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2c63525c6ea717d15844258aad707cTest
    https://doi.org/10.1111/luts.12190Test


    أضف إلى المفضلة
  2. 2
    Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis

    المؤلفون: Tadao Akizawa, Kentarou Kuroishi, Junko Tsukada, Yusuke Yamaguchi, Chisato Kameoka

    المصدر: Therapeutic Apheresis and Dialysis. 21:173-179

    مصطلحات موضوعية: medicine.medical_specialty, Constipation, medicine.drug_class, business.industry, medicine.medical_treatment, 030232 urology & nephrology, Phases of clinical research, Hematology, medicine.disease, Gastroenterology, Discontinuation, Phosphate binder, 03 medical and health sciences, Hyperphosphatemia, 0302 clinical medicine, Nephrology, Internal medicine, medicine, 030212 general & internal medicine, medicine.symptom, business, Adverse effect, Dialysis, Kidney disease

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e9528f0c7b5ec2e4e283bb0c32db7891Test
    https://doi.org/10.1111/1744-9987.12502Test


    أضف إلى المفضلة
  3. 3
    Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis: Phase 3 Randomized Trial

    المؤلفون: Kentarou Kuroishi, Yusuke Yamaguchi, Chisato Kameoka, Tadao Akizawa, Hideki Origasa, Junko Tsukada

    المصدر: Therapeutic Apheresis and Dialysis. 20:588-597

    مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, business.industry, medicine.medical_treatment, 030232 urology & nephrology, Hematology, 030204 cardiovascular system & hematology, medicine.disease, Placebo, Gastroenterology, Confidence interval, Phosphate binder, law.invention, 03 medical and health sciences, Hyperphosphatemia, 0302 clinical medicine, Randomized controlled trial, Nephrology, law, Internal medicine, medicine, Clinical endpoint, business, Dialysis, Kidney disease

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::610cdaea44912565f09c1b627ea1bcbaTest
    https://doi.org/10.1111/1744-9987.12461Test


    أضف إلى المفضلة
  4. 4
    Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study

    المؤلفون: Kentarou Kuroishi, Yumiko Nozawa, Hiromi Tabuchi, Daisuke Kato

    المصدر: LUTS: Lower Urinary Tract Symptoms. 10:122-130

    مصطلحات موضوعية: medicine.medical_specialty, Urinary retention, business.industry, Urology, Incidence (epidemiology), 030232 urology & nephrology, medicine.disease, Concomitant drug, 03 medical and health sciences, 0302 clinical medicine, Neurology, Overactive bladder, 030220 oncology & carcinogenesis, Concomitant, medicine, Dysuria, medicine.symptom, business, Mirabegron, Adverse drug reaction, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4d47630c11619a9afc4d8b3fb892a201Test
    https://doi.org/10.1111/luts.12148Test


    أضف إلى المفضلة
  5. 5
    Real-world cardiovascular assessment of mirabegron treatment in patients with overactive bladder and concomitant cardiovascular disease: Results of a Japanese post-marketing study

    المؤلفون: Kana Kuwamoto, Kentarou Kuroishi, Daisuke Kato, Takao Katoh

    المصدر: International Journal of Urology. 23:1009-1015

    مصطلحات موضوعية: Male, medicine.medical_specialty, Urology, 030232 urology & nephrology, Adrenergic beta-3 Receptor Agonists, Angina, 03 medical and health sciences, QRS complex, 0302 clinical medicine, Internal medicine, Heart rate, medicine, Humans, Aged, Marketing, Cardiovascular History, Urinary Bladder, Overactive, business.industry, Incidence (epidemiology), medicine.disease, New York Heart Association Functional Classification, Thiazoles, Overactive bladder, Cardiovascular Diseases, 030220 oncology & carcinogenesis, Anesthesia, Cardiology, Urological Agents, Acetanilides, Female, business, Mirabegron, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b125b8d46b573be489c7ed432bc69a5Test
    https://doi.org/10.1111/iju.13218Test


    أضف إلى المفضلة
  6. 6
    Results of a randomized, double-blind, parallel-group, placebo- and active-controlled, multicenter study of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder in Asia

    المؤلفون: Kentarou Kuroishi, Yosuke Kubota, Yanqun Na, Kyu-Sung Lee, Rajeev Sood, Shigeru Nakaji, Hann-Chorng Kuo

    المصدر: Neurourology and Urodynamics. 34:685-692

    مصطلحات موضوعية: medicine.medical_specialty, business.industry, Urology, media_common.quotation_subject, medicine.disease, Placebo, Urination, Clinical trial, Overactive bladder, Internal medicine, medicine, Physical therapy, Nocturia, Neurology (clinical), Tolterodine, medicine.symptom, Adverse effect, business, Mirabegron, medicine.drug, media_common

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cbdd7453447186842250edf59f32819fTest
    https://doi.org/10.1002/nau.22645Test


    أضف إلى المفضلة
  7. 7
    Long-Term Safety and Efficacy of Bixalomer in Hyperphosphatemic Patients With Chronic Kidney Disease Not on Dialysis

    المؤلفون: Tadao, Akizawa, Junko, Tsukada, Chisato, Kameoka, Kentarou, Kuroishi, Yusuke, Yamaguchi

    المصدر: Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 21(2)

    مصطلحات موضوعية: Hyperphosphatemia, Male, Treatment Outcome, Polyamines, Humans, Female, Middle Aged, Renal Insufficiency, Chronic, Time

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::d043777b18cef4b432f1f199875972ffTest
    https://pubmed.ncbi.nlm.nih.gov/28194884Test


    أضف إلى المفضلة
  8. 8
    Safety and Effectiveness of Mirabegron in Patients with Overactive Bladder in a Real-World Clinical Setting: A Japanese Post-Marketing Study

    المؤلفون: Yumiko, Nozawa, Daisuke, Kato, Hiromi, Tabuchi, Kentarou, Kuroishi

    المصدر: Lower urinary tract symptoms. 10(2)

    مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Urinary Bladder, Overactive, Prostatic Hyperplasia, Adrenergic beta-3 Receptor Agonists, Middle Aged, Urinary Retention, Severity of Illness Index, Drug Administration Schedule, Diabetes Complications, Thiazoles, Treatment Outcome, Hypertension, Product Surveillance, Postmarketing, Quality of Life, Humans, Urological Agents, Acetanilides, Female, Aged

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::22e8def4d9c9ff4fb4f6383c228de39cTest
    https://pubmed.ncbi.nlm.nih.gov/31009978Test


    أضف إلى المفضلة
  9. 9
    Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

    المؤلفون: Atsushi Nakajima, Hiraku Akiho, Yoshikazu Kinoshita, Hiroto Miwa, Toshifumi Ohkusa, Jeffrey M. Johnston, Kentarou Kuroishi, Masanori Kosako, Mark G. Currie, Ayako Nakagawa, Shin Fukudo

    المصدر: Gastroenterology. 152:S515-S516

    مصطلحات موضوعية: medicine.medical_specialty, Chronic constipation, Hepatology, business.industry, Gastroenterology, Placebo-controlled study, Double blind, chemistry.chemical_compound, Dose finding, chemistry, Internal medicine, medicine, business, Linaclotide

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::fb3b551d35e97dd9a5a72967f06c9427Test
    https://doi.org/10.1016/s0016-5085Test(17)31900-5


    أضف إلى المفضلة
  10. 10
    Tu1627 - Linaclotide is Effective and Safe for Patients with Chronic Constipation in Japan: A Phase III Randomized, Double-Blind, Placebo-Controlled Study with a Long-Term Open-Label Extension Study

    المؤلفون: Mark G. Currie, Masanori Kosako, Toshifumi Ohkusa, Shin Fukudo, Hikaru Akiho, Hiroto Miwa, Kenta Hayashi, Atsushi Nakajima, Kentarou Kuroishi, Yoshikazu Kinoshita, Jeffrey M. Johnston

    المصدر: Gastroenterology. 154:S-973

    مصطلحات موضوعية: medicine.medical_specialty, Chronic constipation, Hepatology, business.industry, Extension study, Gastroenterology, Placebo-controlled study, Term (time), Double blind, chemistry.chemical_compound, chemistry, Internal medicine, medicine, Open label, business, Linaclotide

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::27437c71fafd28e9deeaf753f1b1b5a2Test
    https://doi.org/10.1016/s0016-5085Test(18)33271-2


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث